COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,308 Articles (22,772 medRxiv, 8,536 bioRxiv)

Most recent first Previous |  Page 1440: Articles 14391-14400  | Next

Forecast verifications for the real COVID-19 pandemic dynamics in Qatar
Nesteruk, I.
10.1101/2021.06.16.21259018 — Posted: 2021-06-22
The majority of the variation in COVID-19 rates between nations is explained by median age, obesity rate, and island status
Fraiman, J. B., Ludwin-Peery, E., Ludwin-Peery, S.
10.1101/2021.06.14.21258886 — Posted: 2021-06-22
Factors affecting the transmission of SARS-CoV-2 in school settings
Reynolds, C., Ng, S., Yang, W.
10.1101/2021.06.18.21259156 — Posted: 2021-06-22
Modeling the waves of Covid-19
Cherednik, I.
10.1101/2021.06.15.21258969 — Posted: 2021-06-22
Prior sleep-wake behavior predicts mental health resilience among adults in the United States during the COVID-19 pandemic
Czeisler, M. E., Capodilupo, E. R., Weaver, M. D., Czeisler, C. A., Howard, M. E., Rajaratnam, S. M.
10.1101/2021.06.15.21258983 — Posted: 2021-06-22
A Continuous Bayesian Model for the Stimulation COVID-19 Epidemic Dynamics
Xu, Z., Zhang, H., Niu, Y.
10.1101/2021.06.20.21259220 — Posted: 2021-06-22
Evidence-based pandemic preparedness: an infrastructure for population-scale genome-based based testing for COVID-19
Lehrach, H. R., Curtis, J., Lange, B., Ogilvie, L., Gauss, R., Steininger, C., Scholz, E., Kreck, M.
10.1101/2021.06.10.21258526 — Posted: 2021-06-22
Predicting the mutational drivers of future SARS-CoV-2 variants of concern
Maher, M. C., Bartha, I., Weaver, S., Di Iulio, J., Ferri, E., Soriaga, L., Lempp, F. A., Hie, B. L., Bryson, B., Berger, B., Robertson, D. L., Snell, G., Corti, D., Virgin, H. W., Kosakovsky Pond, S., Telenti, A.
10.1101/2021.06.21.21259286 — Posted: 2021-06-22 Discussion: Onsite
Efficacy of Proxalutamide in Hospitalized COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial
Cadegiani, F. A., Fonseca, D. N., McCoy, J., Zimerman, R. A., Mirza, F. N., Correia, M. N., Barros, R. N., Onety, D. C., Israel, K. C. P., Almeida, B. G., Guerreiro, E. O., Medeiros, J. E. M., Nicolau, R. N., Nicolau, L. F., Cunha, R. X., Barroco, M. F. R., da Silva, P. S., Ferreira, G. S., Alcantara, F. R. P., Ribeiro, A. M., de Almeida, F. O., de Souza, A. A., do Rosario, S. S., Paulain, R. W., Reis, A., Li, M., Thompson, C. E., Nau, G. J., Wambier, C. G., Goren, A.
10.1101/2021.06.22.21259318 — Posted: 2021-06-22 Discussion: Onsite | Offsite
Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial
Derde, L. P. G., The REMAP-CAP Investigators
10.1101/2021.06.18.21259133 — Posted: 2021-06-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).